Joseph K. Schachle
Chief Operating Officer · Opus Genetics, Inc.
- 2026
- Jul 27, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Joseph K. Schachle files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Foundation Fighting Blindness Retinal Degeneration Fund - $10.15M in IRD purchases and sales in the last 12 months
- Cam Gallagher - $324K in IRD purchases and sales in the last 12 months
- George Magrath - $205K in IRD purchases and sales in the last 12 months
- Robert E. Gagnon - $191K in IRD purchases and sales in the last 12 months
- Benjamin R. Yerxa - $61K in IRD purchases and sales in the last 12 months
- Ashwath Jayagopal - $58K in IRD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Joseph K. Schachle?
Joseph K. Schachle is a corporate insider, tracked as Chief Operating Officer of Opus Genetics, Inc. (IRD). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Joseph K. Schachle submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Joseph K. Schachle been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($58K) across all tracked filings.
